Comparing Symptoms of Anxiety Disorders and Related Transdiagnostic Factors in Cancer Patients and Healthy Individuals

Document Type : Research Paper

Authors

1 Department of Psychology, Neyshabur Branch, Islamic Azad Uniuersity, Neyshabur, Iran

2 MSc in Clinical Psychology, Mashhad University of Medical Sciences, Ibn Sina Hospital, Mashhad, Iran, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Introduction:
This study aimed to compare symptoms of anxiety disorders and related transdiagnostic factors in cancer patients and healthy individuals.
Materials and Methods: 
In this causal-comparative study, 30 patients with cancer and 30 healthy individuals were selected by the convenience sampling method. The groups were matched in demographic characteristics with each other. The participates completed the Generalized Anxiety Disorder Scale-7 (2006), Severity Measure for Panic Disorder-Adult (2013), Social Phobia Inventory (2000), Cognitive Avoidance Questionnaire (2008), Intolerance of Uncertainty Scale (1994), Metacognition Questionnaire (2004), Acceptance and Action Questionnaire-II (2011), and Cognitive Emotion Regulation Questionnaire (2006). Data were analyzed by SPSS software (version 24), using a one-way analysis of variance. The significance level was 0.05.
Results: 
The results showed that there was a significant difference between the two groups in symptoms of generalized anxiety (GAD) and panic disorders (PD) (P<0.05). However, no significant difference was observed in symptoms of a social anxiety disorder (P>0.05). In addition, there was a significant difference between the two groups in all transdiagnostic factors (P<0.05).
Conclusion: 
Individuals with cancer were reported more symptoms of GAD and PD and related transdiagnostic factors than those in the control group.

Keywords


  1. World Health Organization. Cancer. Fact sheet; 2018.
  2. American Cancer Society. Cancer facts & figures; 2017.
  3. Kolahdoozan S, Sajadi A, Radmard AR, Khademi H. Five common cancers in Iran. Archives of Iranian medicine.2010;13(2):143-46.
  4. Jalili M, Khodabakhshi Koolaee A. Relationship between health literacy and general health among patients with leukemia before bone marrow transplant. IJCA. 2016; 1(1):1-7. [In Persian].
  5. ChopraI, Kamal KM. A systematic review of quality of life instruments in long-term breast cancer survivors. Health Qual Life Outcomes. 2012; 10:14.
  6. Maher Managing the consequences of cancer treatment and the English National Cancer Survivorship Initiative. Acta Oncol. 2013; 52(2):225-32.
  7. Hernández Blázquez M, Cruzado JA. A longitudinal study on anxiety, depressive and adjustment disorder, suicide ideation and symptoms of emotional distress in patients with cancer undergoing radiotherapy. J Psychosom Res. 2016; 87:14-21.
  8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5rd). Washington, DC: American Psychiatric Association; 2013.
  9. Smith KJ, Béland M, Clyde M, Gariépy G, Pagé V, Badawi G, Rabasa-Lhoret R, Schmitz N. Association of diabetes with anxiety: A systematic review and meta-analysis. J Psychosom Res. 2013; 74(2):89-99.
  10. Fritzsche K, Liptai C, Henke M. Psychosocial distress and need for psychotherapeutic treatment in cancer patients undergoing radiotherapy. Radiother Oncol. 2004;72(2):183-9
  11. Mehnert A, Lehmann C, Graefen M, Huland H, Koch U. Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. Eur J Cancer Care (Engl). 2010; 19(6):736-45.
  12. Spencer R, Nilsson M, Wright A, Pirl W, Prigerson H. Anxiety disorders in advanced cancer patients: Correlates and predictors of end-of-life outcomes. Cancer. 2010; 116(7):1810-19.
  13. Aldao, A. Emotion regulation strategies as transdiagnostic processes: A closer look at the invariance of their form and function. Revista de Psicopatologia y Psicologia Clinica. 2012; 17:
    261-78.
  14. Koerner N, Dugas MJ. An investigation of appraisals in individuals vulnerable to excessive worry: the role of intolerance of uncertainty. Cogn Ther Res. 2007; 32(5):619-38.
  15. Wells A. Metacognitive theory and therapy for worry and generalized anxiety disorder: Review and status. J Ex Psychopathol. 2010; 1(1):133-45.
  16. Hayes S, Levin M, Plumb-Vilardaga J, Villatte J, Pistorello J. Acceptance and commitment therapy and contextual behavioral science: Examining the progress of a distinctive model of behavioral and cognitive therapy. Behav Ther. 2013; 44(2): 18098.
  17. Thompson RA. Emotion regulation: A theme in search of definition. Monogr Soc Res Child Dev. 1994; 59(203):25-52.
  18. Thompson RA. Emotion dysregulation: A theme in search of definition. Dev Psychopathol. 2019; 31(3):805-815.
  19. Thompson RA. Emotional regulation and emotional development. Edu Psychol Rev. 1991; 3(4):269-307.
  20. Garnefski N, Kraaij V. Cognitive emotion regulation questionnaire- development of a short 18-item version (CERQ-short). Pers Individ Dif. 2006; 41:1045-53.
  21. Garnefski N, Kraaij V. Specificity of relations between adolescents’ cognitive emotion regulation strategies and symptoms of depression and anxiety. Cogn Emot. 2018; 32(7): 1401-8.
  22. Gillanders DT, Sinclair AK, MacLean M, Jardine K. Illness cognitions, cognitive fusion, avoidance and self-compassion as predictors of distress and quality of life in a heterogeneous sample of adults, after cancer.  J Contextual Behav Sci. 2015; 4(4):300-11.
  23. Cook SA, Salmon P, Dunn G, Holcombe C, Cornford P, Fisher P. A prospective study of the association of metacognitive beliefs and processes with persistent emotional distress after diagnosis of cancer. Cognit Ther Res. 2015; 39:51-60.

 

  1. Ghanbari Jektaji M, Khalkali V. Compare of metacognitive beliefs in women with breast cancer and healthy women. Cumhuriyet Science Journal. 2015, 36:1947-54.
  2. Eisenberg SA, Kurita K, Taylor-Ford M, Agus DB, Gross ME, Meyerowitz BE. Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors. Psychooncology. 2015; 24(2):228-35.
  3. Salber KE. Experiential Avoidance and Distress in Breast Cancer Patients. Doctor of Philosophy. Drexel University; 2015.
  4. Azizi A, Mir Derikvan F, Mohamadi J. Comparison of personality factors and cognitive emotional regulation in gastric and lung cancer patients and normal subjects. Razi Journal of Medical Sciences. 2015; 22(132):1-9. [In Persian].
  5. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-97.
  6. Mansouri M, Khodayarifard M, Besharat MA, Gholamali Lavasani M. Spiritual coping and cognitive emotion regulation strategies as moderating and mediating factors in the relationship between transdiagnostic factors and symptoms of general anxiety disorder: Developing a conceptual model. J Res Behav Sci. 2018; 16(2):130-42. [In Persian].
  7. Connor KM, Davidson JRT, Churchill LE. Sherwood A, Foa E, Weisler RH. Psychometric properties of the Social Phobia Inventory (SPIN): New selfrating scale. Br J Psychiatry. 2000; 176:379-86.
  8. Hassanvand Amouzadeh M. Validity and reliability of social phobia inventory in students with social anxiety. J Mazandaran Univ Med Sci. 2016; 26(139):166-77. [In Persian].
  9. American Psychiatric Association. Severity measure for panic disorder—adult. 2013.
  10. Sexton KA, Dugas MJ. The Cognitive avoidance questionnaire: validation of the English translation. J Anxiety Disord.2008; 22(3):355-70.
  11. Freeston, MH, Rhéaume J, Letarte H, Dugas MJ, Ladouceur R. Why do people worry? Pers Individ Dif. 1994; 17:791-802.
  12. Wells A, Cartwright-Hatton S. A short form of the metacognitive questionnaire: Properties of the MCQ30. Behav Res Ther. 2004; 42:385-96.
  13. Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, Waltz T, Zettle RD. (2011). Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 2011; 42(4):676-88.